Distribution of [3H]trans-resveratrol in rat tissues following oral administration

British Journal of Nutrition

Volumn 96, Issue 1, 2006, Pages 62-70

  Abd El Mohsen, Manal ^a   Bayele, Henry ^b   Kuhnle, Gunter ^c   Gibson, Glenn ^a   Debnam, Edward ^b   Srai, S Kaila ^b   Rice Evans, Catherine ^c   Spencer, Jeremy P E ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Distribution; Metabolism; Polyphenol; Radioactive; Resveratrol

Indexed keywords

AGLYCONE; DRUG METABOLITE; FLAVONOID; GLUCURONIDE; RESVERATROL; TRITIUM; DIAGNOSTIC AGENT; ENZYME INHIBITOR; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON FLORA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; RAT; TRANS ISOMER; ABSORPTION; ANIMAL; BRAIN LEVEL; CHEMISTRY; HEART MUSCLE; METABOLISM; METHODOLOGY; ORAL DRUG ADMINISTRATION; SPLEEN; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; GLUCURONIDES; KIDNEY; LIVER; LUNG; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; STILBENES; TISSUE DISTRIBUTION; TRITIUM;

EID: 33746764998     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20061810     Document Type: Article

References (26)

1. Abd El-Mohsen MM, Kuhnle G, Moore K, Debnam E, Srai S, Rice-Evans C & Spencer JP (2005) Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 94, 1-9.
2. Abd El-Mohsen MM, Marks J, Kuhnle G, Rice-Evans C, Moore K, Gibson G, Debnam E & Srai SK (2004) The differential tissue distribution of the citrus flavanone naringenin following gastric instillation. Free Radic Res 38, 1329-1340.
3. Bravo L, Abia R, Eastwood MA & Saura-Calixto F (1994) Degradation of polyphenols (catechin and tannic acid) in the rat intestinal tract. Effect on colonic fermentation and faecal output. Br J Nutr 71, 933-946.
4. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E & Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56, 784-790.
5. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A & Merillon JM (1997) Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci 61, 2103-2110.
6. Goldberg DM, Yan J & Soleas GJ (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36, 79-87.
7. Gross M, Pfeiffer M, Martini M, Campbell D, Slavin J & Potter J (1996) The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiol Biomarkers Prev 5, 711-720.
8. Jager U & Nguyen-Duong H (1999) Relaxant effect of trans-resveratrol on isolated porcine coronary arteries. Arzneimittelforschung 49, 207-211.
9. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC & Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
10. Kimura Y, Okuda H & Arichi S (1985) Effects of stilbene derivatives on arachidonate metabolism in leukocytes. Biochim Biophys Acta 837, 209-212.
11. Lu R & Serrero G (1999) Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 179, 297-304.
12. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP & Ducharme MP (2002) Metabolism and disposition of resveratrol. in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302, 369-373.
13. Rechner AR, Kuhnle G, Bremner P, Hubbard GP, Moore KP & Rice-Evans CA (2002) The metabolic fate of dietary polyphenols in humans. Free Radic Biol Med 33, 220-235.
14. Rechner AR, Pannala AS & Rice-Evans CA (2001) Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic Res 35, 195-202.
15. Scheline RR (1991) CRC Handbook of Mammalian Metabolism of Plant Compounds. Boca Raton, FL: CRC Press.
16. Siemann EH & Creasy LL (1992) Concentration of the phytoaexlin resvertarol in red wine. Am J Enol Viticult 43, 49-52.
17. Soleas GJ, Angelini M, Grass L, Diamandis EP & Goldberg DM (2001) Absorption of trans-resveratrol in rats. In Methods in Enzymology, vol. 335. Flavonoids and Other Polyphenols. San Diego: Academic Press.
18. Soleas GJ, Diamandis EP & Goldberg DM (1997) Resveratrol: a molecule whose time has come? And gone? Clin Biochem 30,91-113.
19. Spencer JP, Chowrimootoo G, Choudhury R, Debnam ES, Srai SK & Rice-Evans C (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224-230.
20. Trela BC & Waterhouse AL (1996) Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 44, 1253.
21. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V & Marchelli R (2005) Bioavailability of trans-resveratrol from red wine in humans. Mol Nutr Food Res 49, 495-504.
22. 14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci 72, 2219-2233.
23. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr & Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377-1382, Epublication 27 August 2004.
24. Wang LX, Heredia A, Song HJ, Zhang Z, Yu B, Davis C & Redfield R (2004) Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity. J Pharm Sci 93, 2448-2457.
25. Wenzel E, Soldo T, Erbersdobler H & Somoza V (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol Nutr Food Res 49, 482-494.
26. Yu C, Shin YG, Chow A, Li YM, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG & von Breemen RB (2002) Human, rat, and mouse metabolism of resveratrol. Pharm Res 19, 1907-1914.